Prevalence of Hemolysin (hlyA)-producing Uropathogenic E. coli and Phenolics-mediated Suppression: Experimental and Bioinformatic Evidence
Article Sidebar
Main Article Content
Abstract
Urinary Tract Infections (UTIs) are common opportunistic diseases, primarily caused by Escherichia coli, which utilizes various virulence factors, including the hlyA gene encoding hemolysin. Phenolic compounds in fruits and vegetables, known for their antimicrobial properties, were examined for their effects on E. coli. This study involved 60 E. coli isolates from Aleppo University Hospital, identified via biochemical and molecular tests. The hemolytic ability was assessed phenotypically, and the hlyA gene was detected using PCR. The impact of pyrogallol and catechol on these isolates was also evaluated. Results showed a 54.6% isolation rate of E. coli, with a higher rate in females (71.7%) than males (28.3%). The 20-40 age group was most affected, comprising 38.4% of cases. Hemolytic activity was observed in 45% of isolates, and the hlyA gene was present in 41.6% of cases. Pyrogallol exhibited a bactericidal effect at high concentrations and mild growth at lower levels, while catechol showed no antibacterial effects. These experimental investigations were validated by docking those polyphenols to the hlyA predicted, validated 3D structure where pyrogallol exhibited stronger binding affinity than catechol (-5.2 vs. -4.8 kcal/mol). The study underscores the significance of the hlyA gene in E. coli virulence and highlights the potential antibacterial properties of phenolic compounds at specific concentrations.
Article Details
Copyright (c) 2025 Hamsho FA, et al.
This work is licensed under a Creative Commons Attribution 4.0 International License.
Yazdanpour Z, Tadjrobehkar O, Shahkhah M. Significant association between genes encoding virulence factors with antibiotic resistance and phylogenetic groups in community acquired uropathogenic Escherichia coli isolates. BMC Microbiol. 2020;20(1):241. Available from: https://doi.org/10.1186/s12866-020-01933-1
Ghavidel M, Gholamhosseini-Moghadam T, Nourian K, Ghazvini K. Virulence factors analysis and antibiotic resistance of uropathogenic Escherichia coli isolated from patients in northeast of Iran. Iran J Microbiol. 2020;12(3):223-230. Available from: https://pubmed.ncbi.nlm.nih.gov/32685119/
Tabasi M, Karam MR, Habibi M, Yekaninejad MS, Bouzari S. Phenotypic assays to determine virulence factors of uropathogenic Escherichia coli (UPEC) isolates and their correlation with antibiotic resistance pattern. Osong Public Health Res Perspect. 2015;6(4):261-268. Available from: https://doi.org/10.1016/j.phrp.2015.08.002
Bien J, Sokolova O, Bozko P. Role of uropathogenic Escherichia coli virulence factors in development of urinary tract infection and kidney damage. Int J Nephrol. 2012;2012:681473. Available from: https://doi.org/10.1155/2012/681473
Liu B, Zhou C, Zhang Z, Roland JD, Lee BP. Antimicrobial property of halogenated catechols. Chem Eng J. 2021;403:126340. Available from: https://doi.org/10.1016/j.cej.2020.126340
Wang J, Shen X, Yuan Q, Yan Y. Microbial synthesis of pyrogallol using genetically engineered Escherichia coli. Metab Eng. 2018;45:134-141. Available from: https://doi.org/10.1016/j.ymben.2017.12.006
Ahmed N, Zeshan B, Naveed M, Afzal M, Mohamed M. Antibiotic resistance profile in relation to virulence genes fimH, hlyA and usp of uropathogenic E. coli isolates in Lahore, Pakistan. Trop Biomed. 2019;36(2):559-568. Available from: https://pubmed.ncbi.nlm.nih.gov/33597418/
Xicohtencatl-Cortes J, Cruz-Cordova A, Cazares-Dominguez V, Escalona-Venegas G, Zavala-Vega S, Arellano-Galindo J, et al. Uropathogenic Escherichia coli strains harboring tosA gene were associated to high virulence genes and a multidrug-resistant profile. Microb Pathog. 2019;134:103593. Available from: https://doi.org/10.1016/j.micpath.2019.103593
Fonseca-Martínez SA, Martínez-Vega RA, Farfán-García AE, González Rugeles CI, Criado-Guerrero LY. Association between uropathogenic Escherichia coli virulence genes and severity of infection and resistance to antibiotics. Infect Drug Resist. 2023;16:3707-3718. Available from: https://doi.org/10.2147/idr.s391378
Velasco E, Wang S, Sanet M, Fernández-Vázquez J, Jové D, Glaría E, et al. A new role for Zinc limitation in bacterial pathogenicity: modulation of α-hemolysin from uropathogenic Escherichia coli. Sci Rep. 2018;8(1):6535. Available from: https://doi.org/10.1038/s41598-018-24964-1
Murthy AMV, Phan MD, Peters KM, Nhu NTK, Welch RA, Ulett GC, et al. Regulation of hemolysin in uropathogenic Escherichia coli fine-tunes killing of human macrophages. Virulence. 2018;9(1):967-980. Available from: https://doi.org/10.1080/21505594.2018.1465786
Nhu NTK, Phan MD, Forde BM, Murthy AM, Peters KM, Day CJ, Schembri MA. Complex multilevel control of hemolysin production by uropathogenic Escherichia coli. MBio. 2019;10(5):e02248-19. Available from: https://doi.org/10.1128/mbio.02248-19
Batey SF, Davie MJ, Hems ES, Liston JD, Scott TA, Alt S, et al. The catechol moiety of obafluorin is essential for antibacterial activity. RSC Chem Biol. 2023;4(11):926-941. Available from: https://doi.org/10.1039/D3CB00127J
Oyaert M, Delanghe J. Progress in automated urinalysis. Ann Lab Med. 2019;39(1):15-22. Available from: https://doi.org/10.3343/alm.2019.39.1.15
Tewawong N, Kowaboot S, Pimainog Y, Watanagul N, Thongmee T, Poovorawan Y. Distribution of phylogenetic groups, adhesin genes, biofilm formation, and antimicrobial resistance of uropathogenic Escherichia coli isolated from hospitalized patients in Thailand. PeerJ. 2020;8:e10453. Available from: https://doi.org/10.7717/peerj.10453
Garrity GM, Brenner DJ, Krieg NR, Staley JR. Systematic bacteriology. The Proteobacteria, Part C: The Alpha-, Beta-, Delta-, and Epsilonproteobacteria. In: Bergey’s Manual of Systematic Bacteriology. 2nd ed. New York: Springer; 2005. Available from: https://scirp.org/reference/referencespapers?referenceid=42923
Al-Hadithi HA. Molecular detection of Hemolycin in Escherichia coli and attempt to inhibition by using the Probiotics. Tikrit J Pure Sci. 2018;23(6):79-90. Available from: http://dx.doi.org/10.25130/tjps.v23i6.675
Taneike I, Zhang HM, Wakisaka-Saito N, Yamamoto T. Enterohemolysin operon of Shiga toxin-producing Escherichia coli: a virulence function of inflammatory cytokine production from human monocytes. FEBS Lett. 2002;524(1-3):219-224. Available from: https://doi.org/10.1016/s0014-5793(02)03027-2
Emamghorashi F, Farshad S, Kalani M. Relationship between O serotype and virulent genes in Escherichia coli causing urinary tract infections. Iran J Kidney Dis. 2011;5(4):234-237. Available from: https://sid.ir/paper/309065/en
Johnson JR, Stell AL. Erratum: Extended virulence genotypes of Escherichia coli strains from patients with urosepsis in relation to phylogeny and host compromise. J Infect Dis. 2000;181(6):2122.
Lima VN, Oliveira-Tintino CD, Santos ES, Morais LP, Tintino SR, Freitas TS, et al. Antimicrobial and enhancement of the antibiotic activity by phenolic compounds: Gallic acid, caffeic acid and pyrogallol. Microb Pathog. 2016;99:56-61. Available from: https://doi.org/10.1016/j.micpath.2016.08.004
Abramson J, Adler J, Dunger J, Evans R, Green T, Pritzel A, et al. Accurate structure prediction of biomolecular interactions with AlphaFold 3. Nature. 2024;630:493–500. Available from: https://doi.org/10.1038/s41586-024-07487-w
Lee GR, Won J, Heo L, Seok C. GalaxyRefine2: simultaneous refinement of inaccurate local regions and overall protein structure. Nucleic Acids Res. 2019;47(W1):W451–W455. Available from: https://doi.org/10.1093/nar/gkz288
Schwede T, Kopp J, Guex N, Peitsch MC. SWISS-MODEL: an automated protein homology-modeling server. Nucleic Acids Res. 2003;31(13):3381–3385. Available from: https://doi.org/10.1093/nar/gkg520
Tian W, Chen C, Lei X, Zhao J, Liang J. CASTp 3.0: computed atlas of surface topography of proteins. Nucleic Acids Res. 2018;46(W1):W363–W367. Available from: https://doi.org/10.1093/nar/gky473
Liu Y, Yang X, Gan J, Chen S, Xiao ZX, Cao Y. CB-Dock2: improved protein–ligand blind docking by integrating cavity detection, docking and homologous template fitting. Nucleic Acids Res. 2022;50(W1):W159–W164. Available from: https://doi.org/10.1093/nar/gkac394
Ponnusamy P, Natarajan V, Sevanan M. In vitro biofilm formation by uropathogenic Escherichia coli and their antimicrobial susceptibility pattern. Asian Pac J Trop Med. 2012;5(3):210–213. Available from: https://doi.org/10.1016/s1995-7645(12)60026-1
Shah C, Baral R, Bartaula B, Shrestha LB. Virulence factors of uropathogenic Escherichia coli (UPEC) and correlation with antimicrobial resistance. BMC Microbiol. 2019;19:204. Available from: https://doi.org/10.1186/s12866-019-1587-3
Zamani H, Salehzadeh A. Biofilm formation in uropathogenic Escherichia coli: association with adhesion factor genes. Turk J Med Sci. 2018;48(1):162–167. Available from: https://doi.org/10.3906/sag-1707-3
Salman RS, Hussin SS. A multiplex PCR for detection of hlyA, papC, and traT genes in multidrug resistance Escherichia coli isolated from pregnant women. Al Mustansiriyah J Pharm Sci. 2013;13(2):129-138. Available from: https://doi.org/10.32947/ajps.v13i2.219
Baby S, Karnaker VK, Geetha RK. Determination of phenotypic expression of the fimbriae and hemolysin of uropathogenic Escherichia coli (UPEC). Int J Adv Med. 2014;1(1):13-18. Available from: https://www.ijmedicine.com/index.php/ijam/article/view/435
Jadhav S, Hussain A, Devi S, Kumar A, Parveen S, Gandham N, et al. Virulence characteristics and genetic affinities of multiple drug resistant uropathogenic Escherichia coli from a semi urban locality in India. PLoS One. 2011;6(3):e18063. Available from: https://doi.org/10.1371/journal.pone.0018063
Kumar N, Bhat S, Bhat A, Saralaya V, Mulki SS. Characterization of virulence factors and antibiotic resistance pattern of uropathogenic Escherichia coli strains in a tertiary care center. F1000Res. 2022;11:1163. Available from: https://doi.org/10.12688/f1000research.125596.2
Moeinizadeh H, Shaheli M. Frequency of hlyA, hlyB, hlyC/em> and hlyD genes in uropathogenic Escherichia coli isolated from UTI patients in Shiraz. GMS Hyg Infect Control. 2021;16:Doc25. Available from: https://doi.org/10.3205/dgkh000396
Al–Ubaidy A, Al-Ibadi M. Detection of urovirulence genes (eae, E-hly, α-hly) of uropathogenic Escherichia coli by specific PCR. J Biotechnol Res Cent. 2010;4(1):44–54. Available from: https://doi.org/10.24126/jobrc.2010.4.1.93
Dadi BR, Abebe T, Zhang L, Mihret A, Abebe W, Amogne W. Distribution of virulence genes and phylogenetics of uropathogenic Escherichia coli among urinary tract infection patients in Addis Ababa, Ethiopia. BMC Infect Dis. 2020;20:108. Available from: https://doi.org/10.1186/s12879-020-4844-z
Asadi S, Kargar M, Solhjoo K, Najafi A, Ghorbani-Dalini S. The association of virulence determinants of uropathogenic Escherichia coli with antibiotic resistance. Jundishapur J Microbiol. 2014;7(5):e9936. Available from: https://doi.org/10.5812/jjm.9936
Derakhshan S, Ahmadi S, Ahmadi E, Nasseri S, Aghaei A. Characterization of Escherichia coli isolated from urinary tract infection and association between virulence expression and antimicrobial susceptibility. BMC Microbiol. 2022;22(1):89. Available from: https://doi.org/10.1186/s12866-022-02506-0
Oliveira FA, Paludo KS, Arend LNVS, Farah SMSS, Pedrosa FO, Souza EM, et al. Virulence characteristics and antimicrobial susceptibility of uropathogenic Escherichia coli strains. Genet Mol Res. 2011;10(4):4114–4125. Available from: https://doi.org/10.4238/2011.october.31.5
Chew YL, Goh JK, Arasi C. Investigation on antibacterial activity of pyrogallol in methicillin resistant Staphylococcus aureus. Curr Trends Biotechnol Pharm. 2020;14(5):176–180. Available from: http://dx.doi.org/10.5530/ctbp.2020.4s.20